TAD After Chemotherapy in Locally Advanced Breast Cancer
NCT05763641 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 162
Last updated 2025-09-10
Summary
This is an observational study to validate target axillary dissection (TAD) in locally advanced tumors (cN2 and/or cT4).
Conditions
- Sentinel Lymph Node
- Breast Cancer
- Locally Advanced
Interventions
- PROCEDURE
-
Target Axillary Dissection
TAD after neoadjuvant chemotherapy and subsequent axillary lymph node dissection
Sponsors & Collaborators
-
Hospital Universitari de Bellvitge
lead OTHER
Principal Investigators
-
amparo Garcia-Tejedor, MDPhD · Instituto de Investigación Biomédica de Bellvitge (IDIBELL)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2026-06-01
- Completion
- 2026-06-01
Countries
- Spain
Study Locations
More Related Trials
-
Prospective Evaluation of Targeted Axillary Dissection (TAD)
NCT04998682 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
NCT05676866 ·Status: UNKNOWN ·Phase: PHASE4
-
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726 ·Status: RECRUITING
-
Preoperative and Intraoperative Quantification of Axillary Tumoral Load
NCT02197949 ·Status: TERMINATED
-
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
NCT04744506 ·Status: RECRUITING ·Phase: NA
-
Validation of TAD in HER-2 with More Than 2 Lymph Nodes
NCT06821490 ·Status: ENROLLING_BY_INVITATION
-
AXillary Surgery After NeoAdjuvant Treatment
NCT04373655 ·Status: RECRUITING
-
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
NCT04109079 ·Status: RECRUITING ·Phase: NA
-
Carbon Dye Tattooing of Biopsied Axillary Node in Breast Cancer
NCT03640819 ·Status: COMPLETED ·Phase: NA
-
ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer
NCT04889924 ·Status: RECRUITING ·Phase: NA
-
Sentinel Node Vs Observation After Axillary Ultra-souND
NCT02167490 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172 ·Status: RECRUITING ·Phase: NA
-
Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer
NCT00165243 ·Status: COMPLETED ·Phase: PHASE2
-
Mastectomy in Ambulatory Breast Surgery
NCT03003169 ·Status: COMPLETED
-
Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer
NCT00210236 ·Status: TERMINATED ·Phase: PHASE3
-
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With Implant
NCT05213962 ·Status: ENROLLING_BY_INVITATION
-
Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention
NCT02318615 ·Status: UNKNOWN ·Phase: NA
-
MUltimodal Targeted Axillary Surgery
NCT04039893 ·Status: UNKNOWN ·Phase: NA
-
Interhospital Variability in Programmes to Prevent Axillary Lymphadenectomy Sequels in Breast Cancer Patients.
NCT03300349 ·Status: COMPLETED
-
Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast
NCT00003404 ·Status: COMPLETED ·Phase: NA
-
RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)
NCT03643861 ·Status: RECRUITING ·Phase: NA
-
APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer
NCT00402519 ·Status: UNKNOWN ·Phase: PHASE3
-
Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer
NCT04098926 ·Status: COMPLETED ·Phase: NA
-
Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer
NCT00014612 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment
NCT02017496 ·Status: TERMINATED